PRO-C3 Launched by Roche Diagnostics on cobas Analyzers
Nordic Bioscience's PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a way to assess liver fibrosis.
Nordic Bioscience's PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a way to assess liver fibrosis.
Roche received 510(k) clearance from the FDA for the cobas pure integrated solutions, new to the cobas family of Serum Work Area solutions.
The test provides healthcare professionals with a single result to confirm HIV diagnosis and to differentiate HIV-1 and HIV-2.